Active Lyn in CLL cells could regulate additional inhibitory signaling by phosphorylating ITIMs within CD32b, CD72, CD22, and Siglec-10, all of which would then attract SHP-1 and SHIP-1 to initiate this process. The gene discussed is INPP5D; the disease is B-cell chronic lymphocytic leukemia.